Combined Oral and Parenteral Nutritional Therapy After Gastrectomy for Gastric Cancer
BRIDGE-GC
Bridging the Postoperative Nutritional Gap After Gastrectomy for Gastric Cancer: A Prospective Randomized Trial of Combined Oral and Parenteral Nutritional Therapy
1 other identifier
interventional
55
1 country
1
Brief Summary
Patients undergoing gastrectomy for gastric cancer frequently experience insufficient oral intake during the postoperative recovery period because of reduced gastric capacity, early satiety, and gastrointestinal symptoms. Although oral nutritional supplements (ONS) are commonly recommended, adherence is often poor, resulting in a postoperative nutritional gap. This prospective randomized clinical trial was designed to evaluate the impact of combined oral and parenteral nutritional therapy on nutritional status and recovery after gastrectomy for gastric cancer. Patients were randomized to either a combined nutritional therapy group receiving oral nutritional supplementation plus parenteral nutrition or a control group receiving standard postoperative care. The primary endpoint was postoperative body weight change at 4 weeks after surgery. Secondary endpoints included body composition, nutritional intake, inflammatory and immune markers, laboratory parameters, and quality of life outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2024
CompletedFirst Submitted
Initial submission to the registry
May 17, 2026
CompletedFirst Posted
Study publicly available on registry
May 22, 2026
CompletedMay 22, 2026
May 1, 2026
3.7 years
May 17, 2026
May 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Body Weight Change
Difference between preoperative body weight and body weight measured at 4 weeks after gastrectomy for gastric cancer.
4 weeks after surgery
Secondary Outcomes (1)
Body Mass Index Change
4 weeks after surgery
Study Arms (2)
Combined Nutritional Therapy
EXPERIMENTALPatients received combined oral nutritional supplementation and parenteral nutritional support during the postoperative recovery period after gastrectomy for gastric cancer.
Standard Postoperative Care
ACTIVE COMPARATORPatients received standard postoperative nutritional management according to institutional clinical pathways after gastrectomy for gastric cancer.
Interventions
Patients received oral nutritional supplementation using Encover® three times daily during the postoperative recovery period after gastrectomy for gastric cancer.
Supplemental parenteral nutrition was administered during hospitalization and after discharge to support postoperative nutritional requirements.
Standard postoperative nutritional management according to institutional clinical pathways, including routine postoperative diet advancement and conventional nutritional support.
Eligibility Criteria
You may qualify if:
- Age 20 to 80 years
- Histologically confirmed gastric cancer
- Scheduled for curative total or subtotal gastrectomy
- Ability to tolerate oral intake
- Residence within areas covered by home care services
- Written informed consent
You may not qualify if:
- Body mass index (BMI) ≥30 kg/m² or \<18.5 kg/m²
- Uncontrolled diabetes mellitus
- Severe hepatic or renal dysfunction
- Active malignancy other than gastric cancer
- Previous chemotherapy or radiotherapy
- Allergy to oral nutritional supplement products
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kyo Young Songlead
Study Sites (1)
Seoul St. Mary's Hospital
Seoul, Seoul, 06591, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Because of the nature of the nutritional intervention, participants and investigators were not blinded to treatment allocation.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor, Department of Surgery
Study Record Dates
First Submitted
May 17, 2026
First Posted
May 22, 2026
Study Start
October 1, 2020
Primary Completion
May 31, 2024
Study Completion
May 31, 2024
Last Updated
May 22, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share